The present invention presents with novel N-[(pyrimidinylamino) propanil]-, N-[(pyridylamino) propanil]-and N-[(pyrazinylamino) -propanil] arylcarboxamide derivatives, processes for their preparation, they Containing pharmaceutical compositions, and their use in the treatment, particularly in the treatment or prevention of conditions associated with the orexin subtype 1 receptor.
展开▼